Congenital Tuberculosis Complicated by Hemophagocytic Lymphohistiocytosis

Joshua Osowicki1, Shiqi Wang, Christopher McKenzie

  • 1From the *Infectious Diseases Unit, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia; †Division of Pediatric Infectious Diseases, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada; ‡Murdoch Children's Research Institute; §Department of General Medicine, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia; ¶Paediatric Department, Likas Women's and Children's Hospital, Sabah, Malaysia; and ‖Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Insights

Congenital tuberculosis complicated by hemophagocytic lymphohistiocytosis is rare in nonendemic areas. Successful treatment involved antituberculous therapy and corticosteroids, highlighting an unusual but manageable pediatric case.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Congenital tuberculosis is a rare condition presenting a diagnostic challenge, particularly in nonendemic regions.
  • Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome.
  • The co-occurrence of congenital tuberculosis and HLH is exceptionally uncommon in infants.

Observation:

  • A male infant in a nonendemic setting was diagnosed with congenital tuberculosis.
  • The infant subsequently developed hemophagocytic lymphohistiocytosis, complicating the clinical course.
  • This presentation represents a rare dual diagnosis in pediatric medicine.

Findings:

  • Successful management was achieved using a combination of standard antituberculous therapy and corticosteroid administration.
  • The infant demonstrated a positive clinical response to the combined treatment regimen.
  • This case highlights the potential for successful outcomes despite the severity of the combined conditions.

Implications:

  • Early recognition and prompt treatment are crucial for managing congenital tuberculosis and associated HLH.
  • The findings suggest that a combined therapeutic approach can be effective in this rare pediatric scenario.
  • Further research into the pathophysiology and optimal management strategies for this dual condition is warranted.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
707
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
870